Learn more Your daily snapshot of the most important new products, independently curated by our editors. Published 18 ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...